Menu Search
Equities

Laxapana PLC

LITE.N0000:CSE

Laxapana PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (LKR)16.80
  • Today's Change0.00 / 0.00%
  • Shares traded50.63k
  • 1 Year change+15.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in LKRIncome statement in LKRView more

Year on year Laxapana PLC grew revenues 9.16% from 915.64m to 999.52m while net income improved 90.71% from 134.00m to 255.54m.
Gross margin26.42%
Net profit margin18.10%
Operating margin24.24%
Return on assets15.92%
Return on equity29.80%
Return on investment24.07%
More ▼

Cash flow in LKRView more

In 2024, Laxapana PLC increased its cash reserves by 161.32%, or 29.76m. Cash Flow from Financing totalled 257.01m or 25.71% of revenues. In addition the company used 52.05m for operations while cash used for investing totalled 175.20m.
Cash flow per share4.57
Price/Cash flow per share3.70
Book value per share17.12
Tangible book value per share17.12
More ▼

Balance sheet in LKRView more

Laxapana PLC has a Debt to Total Capital ratio of 35.73%, a higher figure than the previous year's 5.09%.
Current ratio1.54
Quick ratio0.7156
Total debt/total equity0.556
Total debt/total capital0.3573
More ▼

Growth rates in LKR

Year on year, growth in earnings per share excluding extraordinary items increased 90.71%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)7.75%
Div growth rate (5 year)--
Payout ratio (TTM)37.05%
EPS growth(5 years)67.83
EPS (TTM) vs
TTM 1 year ago		183.53
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.